Systemic timolol exposure following topical application to infantile hemangiomas. J Am Acad Dermatol 2020 Mar;82(3):733-736
Date
02/23/2019Pubmed ID
30790601DOI
10.1016/j.jaad.2019.02.029Scopus ID
2-s2.0-85076207769 (requires institutional sign-in at Scopus site) 16 CitationsAuthor List
Drolet BA, Boakye-Agyeman F, Harper B, Holland K, Lewandowski A, Stefanko N, Melloni C, Pediatric Trials Network Steering Committee (See Acknowledgments for a listing of committee members.)Author
Kristen E. Holland MD Associate Professor in the Dermatology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Administration, TopicalAdrenergic beta-Antagonists
Hemangioma, Capillary
Humans
Infant
Timolol
